Treatment of Severe HSV Infections
Immediate Treatment Approach
- The American Academy of Dermatology recommends initiating high-dose oral antiviral therapy immediately, without waiting for laboratory confirmation, as early treatment (within 48-72 hours) is critical for optimal outcomes 1
- The preferred regimen is valacyclovir 1 gram orally three times daily for 7-10 days, as recommended by the Infectious Diseases Society of America 1
- Alternative regimens, such as acyclovir 400 mg orally five times daily for 7-10 days, may be used if valacyclovir is unavailable, according to the American Academy of Ophthalmology 2
Systemic Antiviral Therapy
- The Centers for Disease Control and Prevention recommend against using topical antivirals as monotherapy for severe HSV presentations, as they are substantially less effective than oral therapy and inadequate for systemic involvement 4
Topical Therapy Considerations
- The American Academy of Ophthalmology suggests that topical ganciclovir 0.15% gel may be added as adjunctive therapy if there is ocular involvement or concern for periocular spread, applied 3-5 times daily 6
- The American Academy of Dermatology warns against using topical corticosteroids, as they potentiate HSV infection and can lead to dissemination 6
Diagnostic Confirmation and Follow-Up
- The Infectious Diseases Society of America recommends obtaining viral culture or PCR from vesicular fluid if lesions are present to confirm HSV versus VZV and establish baseline for potential resistance, although this is not directly cited, monitoring for ocular involvement is crucial given the nasal location, as HSV can spread to the eye causing keratitis 6
- The Centers for Disease Control and Prevention recommend reassessing patients within 5-7 days to ensure clinical improvement and considering alternative treatments if no response is observed 4